身體管理制度鋼板

No.

Intermediate Name產品名稱

CAS No.

7-Methoxy-4-oxo-3,4-dihydroquinazolin-6-yl acetate

3,4-二氫-7-甲氧基-4-氧代喹唑啉-6-醇乙酸酯

Constructing core structure of EGFR inhibitors.   

EGFR治理和改善劑母核

Methyl-d3-amine hydrochloride

氘代甲胺稀鹽酸鹽

7436-22-8

氘代砌塊

tert-Butyl (4R-cis)-6-Chloromethyl-2,2-dimethyl-1,3-dioxane-4-acetate

瑞舒伐他汀鈣D4里頭體

154026-94-5

Starting material of Rosuvastatin Calcium

瑞舒伐他汀鈣鎂片的起止貨品

tert-Butyl (4R-cis)-6-[(acetyloxy)methyl]-2,2-dimethyl-1,3-dioxane-4-acetate

瑞舒伐他汀鈣D5間體

154026-95-6

(R)-(+)-1-Boc-3-aminopyrrolidine

(R)-(+)-1-Boc-3-氨基吡咯烷

147081-49-0

For Ceftobiprole, Sunvozertinib, etc.

手性砌塊

tert-butyl 4-(6-aminopyridin-3-yl)piperidine-1-carboxylate

4 - (6 -氨基吡啶- 3 -基)哌啶- 1 -甲酸叔丁酯

1198408-35-3

Building Block.

聚合砌塊

伏硫西汀

508233-74-7

Intermediate of Vortioxetine

伏硫西汀上面體

Vortioxetine Hydrochloric

伏硫西汀稀鹽酸鹽

Di-tert-butyl Chloromethyl Phosphate
二叔丁基氯甲基磷酸酯

229625-50-7

Intermediate of Fosnetupitant

福奈妥匹坦中間的體

N-tert-butyl-6-chloro-4-(o-tolyl)nicotinamide

N-叔丁基-6-氯-4-鄰甲苯基煙酰胺

Intermediate of Netupitant and Fosnetupitant

奈妥匹坦中間商體

Methyl-[6-(4-methyl-piperazin-1-yl)-4-o-tolyl-pyridin-3-yl]-amine

N-甲基-4-(2-甲基苯基)-6-(4-甲基-1-哌嗪基)-3-吡啶

胺

(S)-3,3,3-Trifluoro-2-hydroxy-2-methylpropionic acid

(S)-2-三氟甲基-2-羥基丙酸

24435-45-8

Building Block

聚合砌塊

(R)-2-三氟甲基-2-羥基丙酸

(4-(2-(dimethylamino)ethoxy)phenyl)(4-hydroxyphenyl)methanone

[4- [2-（二甲氨基氨基）乙氧基]苯基](4-羥苯基)甲酮

173163-13-8

Building Block

組成砌塊

(2S)-2-(二苯基甲基)吡咯烷

Chiral catalyst

手性催化氧化劑

(R)-2-(diphenylmethyl)pyrrolidine

(2R)-2-(二苯基甲基)吡咯烷

22348-31-8